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Table. Primary and Secondary end-points
Study End-points TRA
(N¼261)
TFA
(N¼157)
OR (95 % CI) P
Primary end-points :
30 days Death 18 (6.9%) 23 (14.6%) 0.84 (0.19-1.49) 0.009
1 year Death 23 (8.8%) 24 (15.3%) 0.62 (0.01-1.23) 0.032
2 years Death 24 (9.2%) 26 (16.6%) 0.67 (0.08-1.27) 0.019
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Background: Current guidelines give a class III recommendation to the intra-
procedural use of unfractionated heparin (UFH) in patients pre-treated with enox-
aparin. Aim of our study was to evaluate bleeding complications in patients who
underwent percutaneous coronary interventions (PCI) performed using intraprocedural
crossover of heparin therapy.
Methods: From January 2011 to June 2013, all consecutive patients who underwent
PCI at two Italian hospitals and for whom periprocedural anticoagulant therapy was
known were retrospectively recruited in this analysis. Patients were divided in two
groups according to crossover (Group 1) or not (Group 2) of heparins (from low
molecular weight heparin to UFH). In all patients the low molecular weight heparin
employed was enoxaparin. We performed propensity matched analysis with a 1:2
ratio. The primary end-point was a haemoglobin drop  3 g/dl within 48 hours after
the procedure.
Results: During the 3 years analyzed, 3224 patients underwent PCI and after the
propensity analysis 309 patients were considered eligible for our study: 104 pa-
tients in Group 1 (69  12 years, 78% males) and 205 patients in Group 2 (69 
13 years, 80% males, p¼NS). There were no signiﬁcant differences between the
two groups for body mass index, periprocedural use of antiplatelet therapy,
baseline haemoglobin haematocrit or platelets levels. Most of the procedures were
performed through transradial approach (globally more than 70% of patients). The
use of glycoprotein IIb/IIIa inhibitors was very low accounting for almost 5% of
patients, without differences between the two groups. The primary end-point
did not differ between the two groups (2.9% in Group 1 and 3.4 in Group 2,
p¼ 0.550). Also nadir of haematocrit or haemoglobin levels did not differ between
the two groups. Finally, in hospital, major adverse cardio-cerebrovascular events
did not differ between the two groups (1.9% in Group 1 and 3.9% in Group 2,
p¼ 0.50).
Conclusions: In this retrospective analysis of a large PCI database, the “heparins
crossover” during PCI was not associated with increased bleeding risk.30 days MACE 24 (9.2%) 25 (15.9%) 0.63 (0.03-1.22) 0.029
1 year MACE 41 (16.1%) 36 (22.9%) 0.47 (0.03-0.97) 0.044
2 years MACE 69 (26.4%) 49 (31.2%) 0.79 (0.51-1.22) 0.179
Secondary end-
points:
Major bleeding 9 (3.4%) 22 (14.0%) 0.22 (0.10-0.49) < 0.001
Major vascular access
site complications
8 (3.1%) 18 (11.5%) 0.24 (0.10-0.58) 0.001TCT-828
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Background: Transradial percutaneous coronary intervention (TRI) is associated with
fewer complications, shorter time duration of hospitalization and more patient satis-
faction than transfemoral percutaneous coronary intervention (TFI). However, the data
of economic evaluation about TRI versus TFI is quite limited in China.
Methods: We conducted a retrospective cohort study from the PCI database in
Fuwai Hospital, a single center registry from the largest heart center in China from
January to December in 2010. Using propensity score inverseprobability weighting
(IPW), we compared the inpatient outcomes and the in-hospital costs between TRI and
TFI.
Results: Of 5539 cases in the cohort, 4888 (88.2%) were with TRI procedures.
Complications in the TRI group related to arteriopuncture are less than those in the
TFI group [Odds Ratio (OR) ¼ 0.27, 95% Conﬁdence Interval (CI): 0.17 to 0.93, p ¼
0.0179], and the difference was also statistically signiﬁcant after adjustment with IPW.
The total incidence of in-hospital death, myocardial infarction and revascularization
was higher in the TFI group (OR ¼ 0.68, 95% CI: 0.49 to 0.93, p ¼ 0.0179).The
duration of hospitalization was signiﬁcantly shorter in the TRI group after adjusting
with IPW (6.3 days vs. 7.8 days, difference ¼ 1.5 days, 95% CI: 1.8 days to 1.3 days,
p < 0.0001). Total unadjusted cost was much lower in the TRI group. After adjust-
ment with IPW, the cost in the TRI group is also lower than in the TFI group at the
difference of￥8034. (￥58935 vs.￥66969, difference ¼￥-8034, 95% CI:￥-9446
to ￥-6622, p< 0.0001). The expense not only in PCI operation but also of peri-PCI
procedure was much less in the TRI group than those in the TFI group. (PCI cost:
￥43870 vs.￥47862, difference ¼￥-3992, 95% CI: ￥-5123 to￥-2861; Peri-PCI
cost:￥15065 vs.￥19107, difference ¼￥-4042, 95% CI:￥-4636 to￥-3448, p <
0.0001).
Conclusions: Compared with the TFI approach, TRI was associated with lower
incidence of bleeding complications, shorter duration of in-hospital stay and less
hospitalization costs.B242 JACC Vol 64/11/Suppl B j September 1TCT-829
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Background: Female patients possess a higher risk for poorer outcome in ST segment
elevation myocardial infarction (STEMI). There is possibility that transradial access
(TRA) for primary percutaneous coronary intervention (PPCI) could provide better
outcome than transfemoral access (TFA) in female patients with STEMI.
Methods: From 2007 to 2010, 418 female patients (out of 1808 patients) underwent
PPCI for acute STEMI. The registry recruited all-comers patients with acute STEMI.
Major bleeding and vascular access site complications, death rates, and overall MACE
rates (composite of death, stroke, re MI and TVR) after 2 years follow-up were
compared between TRA and TFA.
Results: TRA for PPCI was performed in 261 patients and 157 underwent TFA PPCI.
The 30-days and 1 year mortality rates were lower in TRA compared to TFA (6.9 vs
14.6%, p ¼ 0.009, and 8.8 vs 15.3%, p¼0.032, respectively). After 2 years follow-up,
the overall MACE rates were similar (26.4% vs 31.2%, p¼0.17). The major bleeding
and major vascular access site complications were more favorable for TRA than TFA
(3.4 vs 14%, p< 0.001, and 3.1 vs 11.5 %, p¼0.001, respectively).Conclusions: Transradial access for primary PCI in female patients provides less
bleeding and lower incidence of vascular access site complications, and better early
clinical outcome in acute STEMI.
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Background: the risk of acute kidney injury (AKI) is a major issue after percutaneous
coronary interventions (PCI), especially in the setting of ST-elevation myocardial
infarction. Preliminary data from large retrospective registries seem to show a
reduction of AKI when a transradial (TR) approach for PCI is adopted. Little is known
about the relation between vascular access and AKI after emergent PCI.
Methods: we here report the results of the PRIPITENA, a retrospective database of
primary-PCI performed at high volume centers in the urban areas of Rome and Milan.
Primary endpoint of this study was the occurrence of AKI in the TR and transfemoral3–17, 2014 j TCT Abstracts/Vascular Access and Intervention - Transradial
